Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leukemia, Myeloid, Acute × plerixafor × Clear all

Phase

Status

Completed 12 Terminated 6 Unknown 2 Withdrawn 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Multiple Myeloma 2 Warts 1 Neutropenia 1 Myeloproliferative Disorders 1 Myelodysplastic Syndromes 1 Lymphoma, Non-Hodgkin 1 Leukopenia 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Infections 1 Immunologic Deficiency Syndromes 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Agammaglobulinemia 1 Acquired Immunodeficiency Syndrome 1

Interventions

venetoclax 115 Azacitidine 90 Cytarabine 62 fludarabine 41 Specimen Handling 33 Cyclophosphamide 33 Biopsy 24 Decitabine 23 Daunorubicin 23 Idarubicin 21 Granulocyte Colony-Stimulating Factor 18 fludarabine phosphate 17 Injections 17 Whole-Body Irradiation 15 gilteritinib 14 Melphalan 14 Busulfan 13 ivosidenib 11 Stem Cell Transplantation 11 Mycophenolic Acid 11 Gemtuzumab 11 Cladribine 11 CPX-351 11 enasidenib 9 decitabine and cedazuridine drug combination 9 revumenib 8 Tacrolimus 8 Magnetic Resonance Spectroscopy 8 Filgrastim 8 tagraxofusp 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06158828 2026-02-13

ABCD-NK

Washington University School of Medicine

Phase 1/2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡